Category Archives: Novartis

Novartis On Its Way To $100

Novartis (NYSE:NVS) announced its second quarter earnings report there this week and I don’t think there was anything in the announcement that should make long investors doubt their current position. Why? Well if we look at the fundamentals of the … Continue reading

Posted in Novartis | Tagged | Leave a comment

Novartis Should Be Bought On A Pullback

Novartis (NYSE:NVS) Should Be Bought On A Pullback. Entresto & Cosentyx drugs really have the ability to drive sales forward. [soundcloud url=”https://api.soundcloud.com/tracks/331755228″ params=”color=ff5500&auto_play=false&hide_related=false&show_comments=true&show_user=true&show_reposts=false” width=”100%” height=”166″ iframe=”true” /]

Posted in Novartis | Tagged | Leave a comment

Novartis Is Worth At Least $80-$85 A Share

In our portfolio as of late, we have refrained from selling option premium for a few reasons. Firstly after the French election over the weekend, the volatility index CBOE Volatility Index (INDEXCBOE:VIX) really contracted and actually collapsed by 27% on the … Continue reading

Posted in Novartis | Tagged | Leave a comment